Regulation of Pharmaceutical Pricing in India

The Supreme Court of India has raised concerns over the excessive markup on life-saving medicines, highlighting the need for stringent price regulation in the pharmaceutical sector. This issue is crucial for UPSC aspirants, especially for GS Paper 2 and 3, which cover governance and economic development. Last Updated: 03-10-2026

Key Facts About Pharmaceutical Pricing Regulation in India

• The Essential Commodities Act, 1955 allows the government to declare medicines as essential commodities, controlling their production, supply, and pricing.
• The Drugs (Prices Control) Order, 2013 provides the legal framework for drug price control in India.
• The National Pharmaceutical Pricing Authority (NPPA) regulates prices, enforces the DPCO, and recovers overcharges from companies.
• Scheduled Drugs are listed in the National List of Essential Medicines (NLEM), which includes 388 medicines and about 1,000 formulations as of 2022.
• For Non-Scheduled Drugs, manufacturers can set the launch price but cannot increase the MRP by more than 10% annually.
• The Drugs and Cosmetics Act, 1940 regulates the import, manufacture, distribution, and sale of drugs and cosmetics in India.
• The Central Drugs Standard Control Organisation (CDSCO) is responsible for the approval of new drugs, conducting clinical trials, and setting drug standards.

India's Pharmaceutical Pricing Challenges

The regulation of pharmaceutical pricing is significant for India's economic and social goals, aiming to ensure affordable healthcare. The sector faces challenges like exorbitant trade margins, information asymmetry, and high out-of-pocket expenditure, which impact India's healthcare system. With medicines constituting about 70% of out-of-pocket expenses, effective regulation is crucial for economic stability and social welfare.

UPSC Relevance

• GS Paper 2: Governance, Constitution, Polity, Social Justice, and International relations - Issues relating to development and management of social sector/services relating to Health.
• GS Paper 3: Economic Development - Inclusive growth and issues arising from it.
• Prelims Angle: Questions may focus on the role of NPPA, provisions of DPCO, and the significance of NLEM.
• Mains Angle: Analytical themes could include the impact of pharmaceutical pricing on public health and economic growth.
• Essay Paper: Topics on healthcare reforms and economic policies could be relevant.

FAQ Section

• What is pharmaceutical pricing regulation?
  Pharmaceutical pricing regulation involves government policies and frameworks like the DPCO and NPPA to control the prices of medicines, ensuring they remain affordable for the public.
• Why is pharmaceutical pricing important?
  Regulating pharmaceutical prices is crucial to prevent exorbitant costs that lead to high out-of-pocket expenditure, ensuring equitable access to essential medicines.
• What are the key features of the DPCO?
  The DPCO provides a legal framework for drug price control, including provisions for scheduled and non-scheduled drugs, and is enforced by the NPPA.